Physicians' preferences for radioiodine treatment of differentiated thyroid cancer in Brazil: an observational study

被引:0
作者
Padovani, Rosalia do Prado
Pansani, Isabella Fagian [1 ]
Marone, Marilia Martins Silveira [1 ]
Vaisman, Fernanda [1 ,2 ]
Maia, Ana Luiza Silva [3 ]
Dora, Jose Miguel Silva [3 ]
Ramos, Helton Estrela [4 ]
Hoff, Ana Amelia Fialho de Oliveira [5 ]
Filho, George Barberio Coura [5 ]
机构
[1] Santa Casa Misericordia Sao Paulo, Fac Ciencias Med, Sao Paulo, SP, Brazil
[2] Inst Nacl Canc, Rio De Janeiro, RJ, Brazil
[3] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil
[4] Univ Fed Bahia, Salvador, BA, Brazil
[5] Inst Canc Estado Sao Paulo Icesp, Sao Paulo, SP, Brazil
来源
ARCHIVES OF ENDOCRINOLOGY METABOLISM | 2024年 / 68卷
关键词
Thyroid nodule; thyroid neoplasms; radiopharmaceuticals; thyroid cancer; papillary thyroid carcinoma; thyrotropin; thyroid diseases; RECOMBINANT HUMAN THYROTROPIN; RADIOACTIVE IODINE; STIMULATING HORMONE; REMNANT ABLATION; ASSOCIATION GUIDELINES; CARCINOMA; THERAPY; MANAGEMENT; IMPACT; WITHDRAWAL;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The aim of this observational, cross-sectional study was to investigate physicians' preferences for radioiodine (RAI) treatment in patients with differentiated thyroid cancer (DTC) in Brazil and the factors influencing RAI indications. Materials and methods: A survey was distributed to physicians potentially involved in DTC care in Brazil to understand the factors influencing RAI indications. The survey collected information on the profiles of the physicians, along with the characteristics of their workplaces and their preferences regarding RAI indications in three hypothetical clinical cases. Cases 1, 2, and 3 described the cases of patients with DTC and variations to the case that included different scenarios to assess how the respondents would change their RAI recommendations. The analysis included the RAI indications across different medical specialties. Results: A total of 175 physicians answered the survey. There was considerable variability in RAI recommendations in all three cases. The training background influenced the respondents' preferences for RAI indications and their approaches to preparing patients for RAI treatment. Conclusion: The findings of this study reaffirm the need for a Brazilian consensus among physicians across multiple specialties to help guide health care professionals treating patients with DTC in Brazil.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 27 条
[11]   Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: Results of an international, randomized, controlled study [J].
Pacini, F ;
Ladenson, PW ;
Schlumberger, M ;
Driedger, A ;
Luster, M ;
Kloos, RT ;
Sherman, S ;
Haugen, B ;
Corone, C ;
Molinaro, E ;
Elisei, R ;
Ceccarelli, C ;
Pinchera, A ;
Wahl, RL ;
Leboulleux, S ;
Ricard, M ;
Yoo, J ;
Busaidy, NL ;
Delpassand, E ;
Hanscheid, H ;
Felbinger, R ;
Lassmann, M ;
Reiners, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (03) :926-932
[12]   Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Pacini, F. ;
Castagna, M. G. ;
Brilli, L. ;
Pentheroudakis, G. .
ANNALS OF ONCOLOGY, 2012, 23 :110-119
[13]   2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer? [J].
Pacini, Furio ;
Fuhrer, Dagmar ;
Elisei, Rossella ;
Handkiewicz-Junak, Daria ;
Leboulleux, Sophie ;
Luster, Markus ;
Schlumberger, Martin ;
Smit, Johannes W. .
EUROPEAN THYROID JOURNAL, 2022, 11 (01)
[14]   Assessment of the Effect of Two Distinct Restricted Iodine Diet Durations on Urinary Iodine Levels (Collected over 24 h or as a Single-Spot Urinary Sample) and Na (+)/I- Symporter Expression [J].
Padovani, Rosalia P. ;
Maciel, Rui M. B. ;
Kasamatsu, Teresa S. ;
Freitas, Beatriz C. G. ;
Marone, Marilia M. S. ;
Camacho, Cleber P. ;
Biscolla, Rosa Paula M. .
EUROPEAN THYROID JOURNAL, 2015, 4 (02) :99-105
[15]  
Perros P, 2014, CLIN ENDOCRINOL, V81, P1, DOI 10.1111/cen.12515
[16]   Thyroid cancer burden and economic impact on the Brazilian public health system [J].
Porto Silva Janovsky, Carolina Castro ;
Bittencourt, Marcia Sommer ;
Pires de Novais, Maykon Anderson ;
Maciel, Rui M. B. ;
Biscolla, Rosa Paula M. ;
Zucchi, Paola .
ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2018, 62 (05) :537-544
[17]  
Robenshtok E, 2012, INDIA J SURG ONCOL, V3, P182, DOI 10.1007/s13193-011-0115-1
[18]   RECOMBINANT HUMAN THYROID-STIMULATING HORMONE TO STIMULATE 131-I UPTAKE FOR REMNANT ABLATION AND ADJUVANT THERAPY [J].
Sabra, Mona M. ;
Tuttle, R. Michael .
ENDOCRINE PRACTICE, 2013, 19 (01) :149-156
[19]   IMPACT OF THERAPY FOR DIFFERENTIATED CARCINOMA OF THE THYROID - AN ANALYSIS OF 706 CASES [J].
SAMAAN, NA ;
MAHESHWARI, YK ;
NADER, S ;
HILL, CS ;
SCHULTZ, PN ;
HAYNIE, TP ;
HICKEY, RC ;
CLARK, RL ;
GEOPFERT, H ;
IBANEZ, ML ;
LITTON, CE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 56 (06) :1131-1138
[20]   Regional differences in opinions on adjuvant radioactive iodine treatment of thyroid carcinoma within Canada and the United States [J].
Sawka, Anna M. ;
Rotstein, Lorne ;
Brierley, James D. ;
Tsang, Richard W. ;
Thabane, Lehana ;
Gafni, Amiram ;
Straus, Sharon ;
Kamalanathan, Shamila ;
Zhao, Boyu ;
Goldstein, David P. ;
Rambaldini, Gloria ;
Ezzat, Shereen .
THYROID, 2007, 17 (12) :1235-1242